Evidence on microplastic exposure and respiratory health outcomes: a systematic review
Therapeutic Advances in Respiratory Disease · 2026
DOI: 10.1177/17534666261465486 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2026. Verfasst von Chen Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Sha…. Hauptthemen laut MEDLINE: Microplastics, Inhalation Exposure, Respiratory Tract Diseases, Air Pollutants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Pudong New Area Health Commission.
Abstract (Originalsprache)
Background
Plastic fragmentation leads to widespread microplastic (MP) pollution. Inhalation of airborne MPs is a key human exposure route. Evidence links MPs to respiratory diseases, but causal mechanisms and real-world risks remain unclear.
Objectives
This review synthesizes evidence on human exposure to airborne MPs and their role in major respiratory diseases. It aims to identify critical knowledge gaps and improve the framework for assessing inhalation health risks.
Design
This is a systematic review study. Data sources and methods: PubMed, Scopus, and Web of Science were searched (up to 15 June 2025) using keywords for MPs and respiratory diseases. Two researchers independently screened articles, extracted data, and assessed the quality of the studies.
Results
A total of 17 studies were included. MPs are found in human lungs and can induce inflammation. Evidence associates chronic exposure with increased risks of COPD, asthma, and pulmonary fibrosis. A major limitation is that experimental animal studies use MP concentrations vastly exceeding environmental levels, limiting real-world risk extrapolation. Research is also disproportionately focused on polystyrene (PS), while occupational data implicate other polymers.
Conclusion
Airborne MPs are a respiratory toxicant, but definitive causal evidence is constrained by a critical gap between experimental and environmentally relevant concentrations and a polymer-specific research bias. Future studies must prioritize environmentally relevant exposures, investigate high-risk polymers, and integrate exposomics with advanced toxicology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
- St. George's University School of Medicine, Wayne, NJ, USA.
- Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai 200120, China.
Förderung
- The National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Pudong New Area Health Commission
Zitieren
APA
Chen, C., Luo, L., Zheng, Y., Ran, L., Li, Z., Guo, Z., Li, Q., Ji, Y., Hua, J., & Wang, N. (2026). Evidence on microplastic exposure and respiratory health outcomes: a systematic review. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666261465486
Vancouver
Chen C, Luo L, Zheng Y, Ran L, Li Z, Guo Z, et al. Evidence on microplastic exposure and respiratory health outcomes: a systematic review. Therapeutic Advances in Respiratory Disease. 2026. doi:10.1177/17534666261465486
BibTeX
@article{Chen2026,
author = {Chen, Chen and Luo, Ling and Zheng, Yanghong and Ran, Linxin and Li, Zhaoqi and Guo, Zhongliang and Li, Qiang and Ji, Yingqun and Hua, Jing and Wang, Na},
title = {Evidence on microplastic exposure and respiratory health outcomes: a systematic review},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
doi = {10.1177/17534666261465486}
}
EUVIMED